LOINC Code 77019-8: Noninvasive prenatal fetal 18 and 21 aneuploidy panel Sequencing (cfDNA)

What is this code?

LOINC codes identify tests, measurements, observations, survey items, and clinical questions in a standardized way. It is associated with the component Noninvasive prenatal fetal 18 & 21 aneuploidy panel. It is commonly used with the system or sample type Plas.cfDNA.

When is it used?

• Used in lab systems, EHRs, and clinical data exchange.
• May identify a test, observation, survey item, or clinical document request rather than a diagnosis.
• Status: ACTIVE
• Order vs observation: Order
• Panel type: Panel
• Method: Sequencing

What it does not mean

• The code identifies the observation or test, not the actual result.

Key facts

• Noninvasive prenatal fetal 18 and 21 aneuploidy panel - Plasma cell-free DNA by Sequencing
• Noninvasive prenatal fetal 18 & 21 aneuploidy panel
• This term was created for, but is not limited in use to, Sequenom Laboratories' VisibiliT panel, which analyzes circulating cell-free DNA extracted from maternal plasma using whole genome sequencing to determine the risk for fetal chromosome 18 and 21 aneuploidies. VisibiliT is indicated for use in pregnant women with average risk for fetal chromosomal aneuploidy.
• Genetics; Gyn; Gynecology; Heredity; Heritable; high-throughput sequencing; HTS; Inherited; Molecular pathology; MOLPATH; Next generation sequencing; NGS; NIP fet 18+21 aneu pnl; OB; ObGyn; Obstetrics; Pan; Panel.molpath; Panl; Pl; Plasma; Plsm; Pnl; Point in time; Random

Where you may see this code

You may see this code in lab systems, lab reports, EHR exports, interoperability feeds, or other structured clinical data exchanges.

Common synonyms

Frequently asked questions